TITLE

Is supplementary iron useful when preterm infants are treated with erythropoietin?

AUTHOR(S)
Ridley, F. C.; Harris, J.; Gottstein, R.; Emmerson, A. J. B.
PUB. DATE
December 2006
SOURCE
Archives of Disease in Childhood;Dec2006, Vol. 91 Issue 12, p1036
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on a study that examines the usefulness of supplementary iron when preterm infants are treated with erythropoietin to reduce the requirement for blood transfusion. A preterm infant on the neonatal intensive care unit has developed anemia, which requires a blood transfusion. Parents of the baby have agreed to allow the baby undergo recombinant human erythropoietin treatment. It was found that low dose treatment do not reduce the requirement for blood transfusion.
ACCESSION #
23528923

 

Related Articles

  • Recombinant erythropoietin and blood transfusion in selected preterm infants. Meyer, M.P.; Sharma, E.; Carsons, M. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jan2003, Vol. 88 Issue 1, pF41 

    Objectives: To comprehensively identify preterm infants likely to require blood transfusion and to investigate the effectiveness of recombinant erythropoietin in this high risk subgroup. Design: Double blind randomised controlled trial. Setting: Neonatal Intensive Care Unit, Middlemore Hospital,...

  • The Effects of the Introduction of a High-Nutrient Transitional Formula on Growth and Development of Very-Low-Birth-Weight Infants. Worrell, L Andre; Thorp, James W; Tucker, Richard; McKinley, Leslie Turner; Chen, James; Chng, Yi-Mei; Vohr, Betty R // Journal of Perinatology;Mar2002, Vol. 22 Issue 2, p112 

    OBJECTIVE: The purpose of this study was to determine the impact of introducing a high-nutrient transitional formula (TF) for use after discharge on the growth and development of premature infants. STUDY DESIGN AND METHODS: This was a cohort study of all surviving infants with a birth weight...

  • ABOUT OUR COVER.  // Neonatal Network;Mar/Apr2015, Vol. 34 Issue 2, p67 

    No abstract available.

  • The demand for neonatal intensive care. Field, D.J.; Hodges, S.; Mason, E.; Burton, P.; Yates, J.; Wale, S. // BMJ: British Medical Journal (International Edition);11/25/89, Vol. 299 Issue 6711, p1305 

    Examines the demand for neonatal intensive care in Great Britain. Problems of the neonatal care in the country; Duration of the intensive care for premature infants; Gap between demand and provision of neonatal care.

  • The Role of High-Dose Oral Iron Supplementation During Erythropoietin Therapy for Anemia of Prematurity. Bader, D; Kugelman, A; Maor-Rogin, N; Weinger-Abend, M; Hershkowitz, S; Tamir, A; Lanir, A; Attias, D; Barak, M // Journal of Perinatology;Jun2001, Vol. 21 Issue 4, p215 

    OBJECTIVE: To assess whether a high intake of oral iron would increase the effect of recombinant human erythropoietin (rHuEPO) on hemoglobin synthesis. METHODS: We studied 30 preterm infants (gestational age 29 ± 1.8 weeks, birth weight 1161 ± 200 g, at age of 28 ± 10 days) who were...

  • Exchange transfusion as rescue therapy in a severely ill premature child with acute renal failure. Demirel, Gamze; Erdeve, Omer; Uras, Nurdan; Oguz, Serife; Dilmen, Ugur // Pediatric Nephrology;May2011, Vol. 26 Issue 5, p821 

    The article presents a case study of a 24-week male infant who was born to a 34-year-old woman by cesarean section. The infant experienced respiratory distress and was transported to a neonatal intensive care unit where physicians administered nasal continuous positive airway pressure (nCPAP)....

  • Treating the Anemic Oncology Patient with Intravenous Iron: Why, When, and How? Sinha, Smeeta; Kalra, Philip A. // European Journal of Clinical & Medical Oncology;2010, Vol. 2 Issue 1, p111 

    Anemia is common in oncology patients and is associated with poor outcomes and reduced quality of life. Anemia can be treated with blood transfusions and/or erythropoietin-stimulating agents (ESAs) in combination with iron. ESAs have been widely used by nephrologists for the management of anemia...

  • Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants. Becquet, Odile; Guyot, Delphine; Kuo, Philippe; Pawlotsky, Françoise; Besnard, Marianne; Papouin, Micheline; Lapillonne, Alexandre // BMC Pediatrics;2013, Vol. 13 Issue 1, p1 

    Background The benefit to risk ratio of the treatment with erythropoietin (EPO) as a means of limiting the number of transfusions in very preterm infants during hospitalization, seems to be modest since the adoption of restrictive transfusion criteria and of policy limiting phlebotomy losses. We...

  • The good news-bad news about premature birth.  // Medical Update;Apr95, Vol. 18 Issue 10, p3 

    Reports on the proper medical care for premature infants. Advances made in the care for premature infants; Recommendation for specialized care in newborn intensive care units; Risks faced by premature infants when they reach school age.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics